Lilly (Eli) management check
LLY · Health Care · Pharmaceuticals · CEO David A Ricks
Filings as of
Closest peers in Pharmaceuticals
- 35LLYLilly (Eli)84
- 181JNJJohnson & Johnson70
- 195ZTSZoetis68
- 261MRKMerck & Co.64
- 277PFEPfizer63
- 335BMYBristol Myers Squibb59
- 369VTRSViatris57
The seven checks
- GoodBeat its chosen peers
Have owners done well?
What $100 became since fiscal 2021
100100thDetail
$100 invested at the start of fiscal 2021 grew to $671, against $154 for the peer group the company picked itself.
- WatchPay only loosely tracked returns
Does pay follow performance?
Pay actually paid $100 value, each on its own scale
5315thDetail
Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.07 with shareholder return. 1 means pay moved in step; below 0, the opposite way.
- Good0.2% of net income
What does the CEO cost owners?
$36.7m pay · $20.6bn net income, FY2025
100100thDetail
$36.7m of reported pay in fiscal 2025, against $20.6bn of net income.
- n/aNo recent CEO filing
Do they own the stock?
——Light activity: no buys, $25.8m sold in six months. 5 of 5 sales ran on pre-arranged 10b5-1 plans.
- GoodShare count shrinking
Are owners being diluted?
Diluted shares −0.2% a year; flagged above +2%
Stock pay 1.0% of revenue
5339thDetail
Diluted shares changed -0.2% a year over the last three fiscal years. Stock-based pay was 1.0% of revenue in the latest year.
- Good6 leadership filings in 3 years
Is leadership stable?
6 filings under 8-K 5.02 in 3 years
CEO: Mr. Ricks
9575thDetail
CEO in the pay table: Mr. Ricks. 6 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.
- GoodNo red flags on file
Are the books clean?
Since 2022
- 0Restated
- 0Auditor changes
- 0Late filings
- 010-K amended
100100thDetail
No restatements, auditor changes or late filings since 2022.
Reading the scores
Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.
Hover a chart for its figures. Detail has the full reading.
Pay versus performance
From the proxy statement filed March 20, 2026.
Pay tied most to adjusted non-GAAP EPS
Other key measuresAdjusted non-GAAP EPSTotal Shareholder ReturnRevenue
Show the figures
| Fiscal year | CEO | CEO pay | Actually paid | Other executives (avg) | $100 became | Peers | Net income |
|---|---|---|---|---|---|---|---|
| 2025 | Mr. Ricks | $36.7m | $75.2m | $10.9m | $671 | $154 | $20.6bn |
| 2024 | — | $29.2m | $80.6m | $6.1m | $478 | $123 | $10.6bn |
| 2023 | — | $26.6m | $120.9m | $7.8m | $359 | $118 | $5.2bn |
| 2022 | — | $21.4m | $64.1m | $5.8m | $223 | $125 | $6.2bn |
| 2021 | — | $21.5m | $75.7m | $4.7m | $166 | $117 | $5.6bn |
Insiders and the CEO's stakeQuiet
- President, Chair, and CEO
- David A Ricks
- Shares held
- 555,278.097
- Latest Form 4
- Nov 3, 2026
Light activity: no buys, $25.8m sold in six months. 5 of 5 sales ran on pre-arranged 10b5-1 plans.
Open-market trades by officers and directors since May 21, 2026.
- SoldAnat HakimEVP, GC & Secretary · 10b5-1 plan$13.0mNov 2, 2026
- SoldPatrik JonssonEVP & President, LLY Int'l · 10b5-1 plan$7.6mAug 17, 2026
- SoldIlya YuffaEVP&Pres, LLY USA&Global Capab · 10b5-1 plan$2.9mJun 10, 2026
- SoldDonald A ZakrowskiSVP, Finance, & CAO · 10b5-1 plan$2.4mAug 10, 2026
Leadership and governance on file
All 8 filings
- Nov 21, 2025Leadership change8-K 5.02
- Nov 19, 2024Leadership change8-K 5.02
- Sep 9, 2024Leadership change8-K 5.02
- Aug 16, 2024Leadership change8-K 5.02
- Jul 10, 2024Leadership change8-K 5.02
- Jun 5, 2024Leadership change8-K 5.02
- Mar 17, 2023Leadership change8-K 5.02
- May 6, 2022Leadership change8-K 5.02
Latest shareholder vote results: May 7, 2026, including the say-on-pay vote.
Where the money went
2021–2025: $30.9bn returned to owners in buybacks and dividends, 64% of net income, and $2.6bn of pay in stock.
Show the figures
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $28.3bn | $28.5bn | $34.1bn | $45.0bn | $65.2bn |
| Net income | $5.6bn | $6.2bn | $5.2bn | $10.6bn | $20.6bn |
| Stock-based pay | $342.8m | $371.1m | $629.0m | $646.0m | $626.0m |
| Buybacks | $1.3bn | $1.5bn | $750.0m | $2.5bn | $4.1bn |
| Dividends | $3.1bn | $3.5bn | $4.1bn | $4.7bn | $5.4bn |
| Diluted shares | 912m | 905m | 903m | 904m | 899m |
Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.